Institutional Manager · CIK 0002111609
Ishara Investments LP
LOS ANGELES, CA · File #028-26490
Latest AUM
$87.5M
Positions
38
Top-10 Concentration
55.9%
Filings
1
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | PRAXIS PRECISION MEDICINES I | PRAX | +40,000 | +$11.8M | $0 |
| NEW | XERIS BIOPHARMA HOLDINGS INC | XERS | +800,000 | +$6.3M | $0 |
| NEW | BIOMARIN PHARMACEUTICAL INC | BMRN | +100,000 | +$5.9M | $0 |
| NEW | AMICUS THERAPEUTICS INC | FOLD | +360,000 | +$5.1M | $0 |
| NEW | ACADIA PHARMACEUTICALS INC | ACAD | +160,000 | +$4.3M | $0 |
| NEW | ANNEXON INC | ANNX | +750,000 | +$3.8M | $0 |
| NEW | NUVATION BIO INC | NUVB | +400,000 | +$3.6M | $0 |
| NEW | BRIDGEBIO PHARMA INC | BBIO | +36,000 | +$2.8M | $0 |
| NEW | PTC THERAPEUTICS INC | PTCT | +36,000 | +$2.7M | $0 |
| NEW | UNITED THERAPEUTICS CORP DEL | UTHR | +5,500 | +$2.7M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202538 pos · $87.5M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | PRAX | 40,000 | $11.8M | 13.48% |
| 2 | XERIS BIOPHARMA HOLDINGS INC | XERS | 800,000 | $6.3M | 7.18% |
| 3 | BIOMARIN PHARMACEUTICAL INC | BMRN | 100,000 | $5.9M | 6.80% |
| 4 | AMICUS THERAPEUTICS INC | FOLD | 360,000 | $5.1M | 5.86% |
| 5 | ACADIA PHARMACEUTICALS INC | ACAD | 160,000 | $4.3M | 4.89% |
| 6 | ANNEXON INC | ANNX | 750,000 | $3.8M | 4.31% |
| 7 | NUVATION BIO INC | NUVB | 400,000 | $3.6M | 4.10% |
| 8 | BRIDGEBIO PHARMA INC | BBIO | 36,000 | $2.8M | 3.15% |
| 9 | PTC THERAPEUTICS INC | PTCT | 36,000 | $2.7M | 3.13% |
| 10 | UNITED THERAPEUTICS CORP DEL | UTHR | 5,500 | $2.7M | 3.06% |
| 11 | BIOCRYST PHARMACEUTICALS INC | BCRX | 300,000 | $2.3M | 2.68% |
| 12 | VAXCYTE INC | PCVX | 50,000 | $2.3M | 2.64% |
| 13 | GENMAB A/S | GNMSF | 70,000 | $2.2M | 2.47% |
| 14 | SYNDAX PHARMACEUTICALS INC | SNDX | 100,000 | $2.1M | 2.40% |
| 15 | VERASTEM INC | VSTM | 270,000 | $2.1M | 2.38% |
| 16 | TARSUS PHARMACEUTICALS INC | TARS | 24,000 | $2.0M | 2.25% |
| 17 | APOGEE ENTERPRISES INC | APOG | 25,000 | $1.9M | 2.16% |
| 18 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 1,320,000 | $1.8M | 2.04% |
| 19 | INSMED INC | INSM | 10,000 | $1.7M | 1.99% |
| 20 | CORCEPT THERAPEUTICS INC | CORT | 44,000 | $1.5M | 1.75% |